Liang Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liang Guo has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
Wen Zeng
Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
26 shared publicationsYihui Huang
Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
25 shared publicationsSichao Chen
Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
24 shared publicationsDanyang Chen
Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
23 shared publicationsMin Wang
Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
23 shared publicationsWei Zhou
From the Department of Plastic Surgery, Zhongnan Hospital of Wuhan University
23 shared publications
Latest Publications
- Open Access
- 10 February 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102916
Environmentally activatable hydrogel for spatiotemporally programmed nitric oxide delivery for diabetic wound healing
- 10 February 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102916
Open AccessEnvironmentally activatable hydrogel for spatiotemporally programmed nitric oxide delivery for diabetic wound healing
- Open Access
- 12 September 2025
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (18) , 9969-9986
EZH2-mediated H3K27me3 links microbial inosine loss to depression: a gut-brain epigenetic switch
Background: Depression, the second most prevalent neurological disorder globally, affects over 300 million people and presents an urgent public health challenge. While gut microbiota dysbiosis is increasingly recognized as a key contributor to depression, the molecular mechanisms linking microbial imbalance to brain dysfunction remain poorly defined.
- 12 September 2025
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (18) , 9969-9986
Open AccessEZH2-mediated H3K27me3 links microbial inosine loss to depression: a gut-brain epigenetic switch
Background: Depression, the second most prevalent neurological disorder globally, affects over 300 million people and presents an urgent public health challenge. While gut microbiota dysbiosis is increasingly recognized as a key contributor to depression, the molecular mechanisms linking microbial imbalance to brain dysfunction remain poorly defined.
- Open Access
- 26 April 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101806
Injectable deferoxamine-loaded microsphere hydrogels for inhibition of ferroptosis and promotion of third-degree burn wound healing
- 26 April 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101806
Open AccessInjectable deferoxamine-loaded microsphere hydrogels for inhibition of ferroptosis and promotion of third-degree burn wound healing
- 7 March 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 156 (3) , 399-409
Combining Action Research and the Teach-Back Method to Improve Perioperative Care in Hair Transplantation
Background: This study aimed to optimize the perioperative clinical care pathway for patients undergoing hair transplantation by integrating action research and the teach-back method, and to validate its clinical application. Methods: A total of 116 patients undergoing hair transplantation were divided into control and experimental groups based on time periods. The control group received conventional care; the experimental group received action research combined with the teach-back method for training and assessment. After 2 iterative cycles of problem identification, planning, action, reflection, and implementation, the care pathway was refined. Outcomes measured included hair follicle survival rate, complication incidence, secondary transplantation rates within 12 months, postoperative self-management, and satisfaction. Results: The experimental group had higher follicle survival rates (Z = 8.788, P = 0.001), lower complication incidence (χ² = 3.940, P = 0.047), improved postoperative self-management (Z = 3.426, P = 0.001), and greater satisfaction (χ² = 4.245, P = 0.039). There was no significant difference between the 2 groups in the occurrence of secondary hair transplantation within 12 months after surgery (P = 0.618). Conclusions: By combining action research with the teach-back method, the authors significantly optimized perioperative care, achieving notable improvements in the survival rate of hair follicle units after surgery, a reduction in the incidence of complications, and enhancements in both postoperative self-management capabilities and patient satisfaction levels. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
- 7 March 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 156 (3) , 399-409
Combining Action Research and the Teach-Back Method to Improve Perioperative Care in Hair Transplantation
Background: This study aimed to optimize the perioperative clinical care pathway for patients undergoing hair transplantation by integrating action research and the teach-back method, and to validate its clinical application. Methods: A total of 116 patients undergoing hair transplantation were divided into control and experimental groups based on time periods. The control group received conventional care; the experimental group received action research combined with the teach-back method for training and assessment. After 2 iterative cycles of problem identification, planning, action, reflection, and implementation, the care pathway was refined. Outcomes measured included hair follicle survival rate, complication incidence, secondary transplantation rates within 12 months, postoperative self-management, and satisfaction. Results: The experimental group had higher follicle survival rates (Z = 8.788, P = 0.001), lower complication incidence (χ² = 3.940, P = 0.047), improved postoperative self-management (Z = 3.426, P = 0.001), and greater satisfaction (χ² = 4.245, P = 0.039). There was no significant difference between the 2 groups in the occurrence of secondary hair transplantation within 12 months after surgery (P = 0.618). Conclusions: By combining action research with the teach-back method, the authors significantly optimized perioperative care, achieving notable improvements in the survival rate of hair follicle units after surgery, a reduction in the incidence of complications, and enhancements in both postoperative self-management capabilities and patient satisfaction levels. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
- Open Access
- 20 February 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1528880
Pharmacological targets and therapeutic mechanisms of Arabic gum in treating diabetic wounds: insights from network pharmacology and experimental validation
Background and objectives: On account of the long-term inflammatory microenvironment, diabetic wounds are challenging to heal in which advanced glycation end products are considered important factors hindering the healing of diabetic wounds. Gum Arabic has demonstrated significant potential in the treatment of various diseases owing to its anti-inflammatory and antioxidant properties. Nonetheless, there is still insufficient research on the role of Arabic gum in facilitating diabetic wounds healing and its mechanisms. This study aims to investigate the pharmacological targets and therapeutic mechanisms of Arabic Gum on diabetic wound healing by adopting network pharmacology, molecular docking, and experimental validation.Methods: Key active components of Arabic Gum and disease targets were identified through network pharmacology and bioinformatics. GO/KEGG enrichment was performed to identify critical pathways. Cytoscape and AutoDock were used for targets prediction and molecular docking validation. In vitro, Transwell assay and tube formation assay were performed to evaluate the effect of Arabic Gum on human fibroblasts migration and human umbilical vein endothelial cells angiogenesis. Western blotting analyzed Pro-caspase-1, ASC, NLRP3 and NF-κB pathway-related proteins. In vivo, a full-thickness diabetic wound model was established. Histological changes were assessed via H&E and Masson’s staining, oxidative stress levels through DHE staining, inflammation levels with IL-1β, CD68 and CD206 staining, angiogenesis and cell proliferation levels were assessed by CD31 and Ki67 staining. The levels of pathway-related proteins were analyzed by NLRP3 and Phospho-NF-κB P65 staining.Results: Network pharmacology analysis identified key targets, encompassing HSP90AA1, STAT3, and PRKCB, involved in the AGEs-NF-κB-NLRP3 signaling axis. Molecular docking demonstrated strong binding affinity between AG components and these targets. In vitro, AG lessened AGEs-induced activation of the NLRP3 inflammasome via modulation of the NF-κB pathway and reinforced cell migration and angiogenesis. In vivo, AG-treated diabetic wounds exhibited accelerated healing, with augmented collagen deposition, lowered oxidative stress and inflammation, and strengthened cell migration and angiogenesis. AG promotes diabetic wound healing by modulating the AGEs-NF-κB-NLRP3 axis, exerting anti-inflammatory, antioxidant, pro-angiogenic, and cell-proliferative effects.Conclusion: This study provides new insights into diabetic wound repair and suggests that AG is a promising therapeutic agent for improving diabetic wound healing.
- 20 February 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1528880
Open AccessPharmacological targets and therapeutic mechanisms of Arabic gum in treating diabetic wounds: insights from network pharmacology and experimental validation
Background and objectives: On account of the long-term inflammatory microenvironment, diabetic wounds are challenging to heal in which advanced glycation end products are considered important factors hindering the healing of diabetic wounds. Gum Arabic has demonstrated significant potential in the treatment of various diseases owing to its anti-inflammatory and antioxidant properties. Nonetheless, there is still insufficient research on the role of Arabic gum in facilitating diabetic wounds healing and its mechanisms. This study aims to investigate the pharmacological targets and therapeutic mechanisms of Arabic Gum on diabetic wound healing by adopting network pharmacology, molecular docking, and experimental validation.Methods: Key active components of Arabic Gum and disease targets were identified through network pharmacology and bioinformatics. GO/KEGG enrichment was performed to identify critical pathways. Cytoscape and AutoDock were used for targets prediction and molecular docking validation. In vitro, Transwell assay and tube formation assay were performed to evaluate the effect of Arabic Gum on human fibroblasts migration and human umbilical vein endothelial cells angiogenesis. Western blotting analyzed Pro-caspase-1, ASC, NLRP3 and NF-κB pathway-related proteins. In vivo, a full-thickness diabetic wound model was established. Histological changes were assessed via H&E and Masson’s staining, oxidative stress levels through DHE staining, inflammation levels with IL-1β, CD68 and CD206 staining, angiogenesis and cell proliferation levels were assessed by CD31 and Ki67 staining. The levels of pathway-related proteins were analyzed by NLRP3 and Phospho-NF-κB P65 staining.Results: Network pharmacology analysis identified key targets, encompassing HSP90AA1, STAT3, and PRKCB, involved in the AGEs-NF-κB-NLRP3 signaling axis. Molecular docking demonstrated strong binding affinity between AG components and these targets. In vitro, AG lessened AGEs-induced activation of the NLRP3 inflammasome via modulation of the NF-κB pathway and reinforced cell migration and angiogenesis. In vivo, AG-treated diabetic wounds exhibited accelerated healing, with augmented collagen deposition, lowered oxidative stress and inflammation, and strengthened cell migration and angiogenesis. AG promotes diabetic wound healing by modulating the AGEs-NF-κB-NLRP3 axis, exerting anti-inflammatory, antioxidant, pro-angiogenic, and cell-proliferative effects.Conclusion: This study provides new insights into diabetic wound repair and suggests that AG is a promising therapeutic agent for improving diabetic wound healing.
- 8 October 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (23) , 4791-4804
Summary of Best Evidence for Perioperative Management Practices in Hair Transplantation Patients
Aim To integrate and summarize the best evidence on perioperative management practices for hair transplantation patients, providing an evidence-based reference for clinical. Methods An exhaustive literature search was conducted to identify the best evidence for managing patients undergoing hair transplantation during the perioperative period. The databases searched included Up To Date, BMJ Best Practice, UK National Institute for Health and Care Excellence, National Guideline Clearing House, Scottish Intercollegiate Guidelines Network, Guidelines International Network, Cochrane Library, JBI Database of Systematic Reviews and Implementation Reports, PubMed, Web of Science, European Dermatology Forum, China National Knowledge Infrastructure, Wanfang Data, Medlive Guideline Network, and Sinomed. The search spanned publications from February 2013 to February 2024, focusing on clinical decisions, evidence summaries, guidelines, and expert consensus. Results We finally identified 22 articles with high-quality results (consisting of 9 clinical decisions, 6 guidelines, 7 expert consensuses), providing 41 pieces of evidence across seven categories: assessment of transplantation conditions, transplant planning and preoperative preparation, anesthetic preparations, surgical methods and operation skills, postoperative wound management, medication-related guidance, optimization of nursing and treatment strategies. Special emphasis has been placed on the sections covering anesthesia preparation, surgical methods, and operational techniques, with detailed explanations provided. Conclusion The summarized best evidence on perioperative management practices for hair transplantation patients can serve as evidence-based guidelines for clinical. It is recommended that clinical staff adopt evidence-based recommendations to improve and optimize patient outcomes and promote postoperative recovery. As these evidences came from different countries, factors such as the clinical environment should be evaluated before application. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 8 October 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (23) , 4791-4804
Summary of Best Evidence for Perioperative Management Practices in Hair Transplantation Patients
Aim To integrate and summarize the best evidence on perioperative management practices for hair transplantation patients, providing an evidence-based reference for clinical. Methods An exhaustive literature search was conducted to identify the best evidence for managing patients undergoing hair transplantation during the perioperative period. The databases searched included Up To Date, BMJ Best Practice, UK National Institute for Health and Care Excellence, National Guideline Clearing House, Scottish Intercollegiate Guidelines Network, Guidelines International Network, Cochrane Library, JBI Database of Systematic Reviews and Implementation Reports, PubMed, Web of Science, European Dermatology Forum, China National Knowledge Infrastructure, Wanfang Data, Medlive Guideline Network, and Sinomed. The search spanned publications from February 2013 to February 2024, focusing on clinical decisions, evidence summaries, guidelines, and expert consensus. Results We finally identified 22 articles with high-quality results (consisting of 9 clinical decisions, 6 guidelines, 7 expert consensuses), providing 41 pieces of evidence across seven categories: assessment of transplantation conditions, transplant planning and preoperative preparation, anesthetic preparations, surgical methods and operation skills, postoperative wound management, medication-related guidance, optimization of nursing and treatment strategies. Special emphasis has been placed on the sections covering anesthesia preparation, surgical methods, and operational techniques, with detailed explanations provided. Conclusion The summarized best evidence on perioperative management practices for hair transplantation patients can serve as evidence-based guidelines for clinical. It is recommended that clinical staff adopt evidence-based recommendations to improve and optimize patient outcomes and promote postoperative recovery. As these evidences came from different countries, factors such as the clinical environment should be evaluated before application. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 4 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281 (Pt 2) , 136309
A novel strategy to enhance inhibition of Hela cervical cancer by combining Lentinus β-glucan and autophagic flux blockage
- 4 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281 (Pt 2) , 136309
A novel strategy to enhance inhibition of Hela cervical cancer by combining Lentinus β-glucan and autophagic flux blockage
- Open Access
- 1 August 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 38, 292-304
Accelerated infected wound healing by probiotic-based living microneedles with long-acting antibacterial effect
Delays in infected wound healing are usually a result of bacterial infection and local inflammation, which imposes a significant and often underappreciated burden on patients and society. Current therapies for chronic wound infection generally suffer from limited drug permeability and frequent drug administration, owing to the existence of a wound biofilm that acts as a barrier restricting the entry of various antibacterial drugs. Here, we report the design of a biocompatible probiotic-based microneedle (MN) patch that can rapidly deliver beneficial bacteria to wound tissues with improved delivery efficiency. The probiotic is capable of continuously producing antimicrobial substances by metabolizing introduced glycerol, thereby facilitating infected wound healing through long-acting antibacterial and anti-inflammatory effects. Additionally, the beneficial bacteria can remain highly viable (>80 %) inside MNs for as long as 60 days at 4 °C. In a mouse model of Staphylococcus aureus-infected wounds, a single administration of the MN patch exhibited superior antimicrobial efficiency and wound healing performance in comparison with the control groups, indicating great potential for accelerating infected wound closure. Further development of live probiotic-based MN patches may enable patients to better manage chronically infected wounds.
- 1 August 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 38, 292-304
Open AccessAccelerated infected wound healing by probiotic-based living microneedles with long-acting antibacterial effect
Delays in infected wound healing are usually a result of bacterial infection and local inflammation, which imposes a significant and often underappreciated burden on patients and society. Current therapies for chronic wound infection generally suffer from limited drug permeability and frequent drug administration, owing to the existence of a wound biofilm that acts as a barrier restricting the entry of various antibacterial drugs. Here, we report the design of a biocompatible probiotic-based microneedle (MN) patch that can rapidly deliver beneficial bacteria to wound tissues with improved delivery efficiency. The probiotic is capable of continuously producing antimicrobial substances by metabolizing introduced glycerol, thereby facilitating infected wound healing through long-acting antibacterial and anti-inflammatory effects. Additionally, the beneficial bacteria can remain highly viable (>80 %) inside MNs for as long as 60 days at 4 °C. In a mouse model of Staphylococcus aureus-infected wounds, a single administration of the MN patch exhibited superior antimicrobial efficiency and wound healing performance in comparison with the control groups, indicating great potential for accelerating infected wound closure. Further development of live probiotic-based MN patches may enable patients to better manage chronically infected wounds.
- 19 August 2023
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 6 (17) , 15620-15631
ZIF-8/Curcumin-Loaded Electrospun Nanofiber Membrane for Wound Healing
- 19 August 2023
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 6 (17) , 15620-15631
ZIF-8/Curcumin-Loaded Electrospun Nanofiber Membrane for Wound Healing